Related Experiment Video
Updated: Aug 12, 2026
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Expression of the epidermal growth factor receptor gene in human brain metastases
1Institute of Cancer Research, Medical Technical Centre, Trondheim, Norway.
Abstract:
Biopsy specimens of human brain metastases were examined for amplification and expression of the proto-oncogene c-erbB1 (located on chromosome 7) encoding the epidermal growth factor receptor (EGFR). Moreover, the tumour DNA was also examined for amplification of other cancer-related genes on this chromosome: the proto-oncogene c-met, the gene for platelet-derived growth factor A-chain, and the gene for plasminogen activator inhibitory type 1. All 18 brain metastases demonstrated positive binding of biotinylated EGF on cryosections. Three out of 18 metastases had amplification of the EGFR gene; the other chromosome-7 genes tested were not amplified. Thus, an increased EGFR gene expression seems to be a general finding in a wide range of carcinomas metastatic to the brain, whereas we found only occasional selective EGFR gene amplifications in single cases.
Insights
Researchers investigated brain metastases, finding increased epidermal growth factor receptor (EGFR) gene expression in most cases. While EGFR gene amplification was occasional, elevated expression suggests a role in brain metastasis for various carcinomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Brain metastases represent a significant challenge in cancer care.
- The epidermal growth factor receptor (EGFR) pathway is implicated in various cancers.
- Understanding genetic alterations in brain metastases is crucial for targeted therapies.
Purpose of the Study:
- To investigate the amplification and expression of the EGFR proto-oncogene (c-erbB1) in human brain metastases.
- To examine the amplification of other cancer-related genes on chromosome 7 in these metastases.
- To correlate EGFR gene status with its expression in brain metastatic lesions.
Main Methods:
- Analysis of biopsy specimens from 18 human brain metastases.
- Examination of tumor DNA for gene amplification using molecular techniques.
- Assessment of EGFR protein expression via biotinylated EGF binding on cryosections.
Main Results:
- All 18 brain metastases showed positive binding of biotinylated EGF, indicating EGFR expression.
- Three out of 18 metastases exhibited amplification of the EGFR gene.
- No amplification was observed for other tested chromosome 7 genes (c-met, PDGF-A, PAI-1).
Conclusions:
- Increased EGFR gene expression is a common finding in a wide range of carcinomas metastatic to the brain.
- Selective EGFR gene amplification occurs only in occasional cases of brain metastases.
- EGFR expression, rather than gene amplification, may be a more general characteristic of brain metastases.
